Association between two common polymorphisms and risk of hepatocellular carcinoma: Evidence from an updated meta-analysis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Zhaoming ^a,b   Zhang, Lei ^a   Shi, Xuesong ^a   Xu, Huayu ^c   Wang, Ting ^c   Bian, Jianmin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 196A2; UNCLASSIFIED DRUG; GENETIC MARKER; MIRN146 MICRORNA, HUMAN; MIRN196 MICRORNA, HUMAN;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; META ANALYSIS (TOPIC); POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; CARCINOMA, HEPATOCELLULAR; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; LIVER NEOPLASMS; MALE; META ANALYSIS; PREVALENCE; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; EVIDENCE-BASED MEDICINE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS;

EID: 84900006596     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/468605     Document Type: Article

References (51)

1. Perz J. F., Armstrong G. L., Farrington L. A., Hutin Y. J. F., Bell B. P., The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology 2006 45 4 529 538 2-s2.0-33748114343 10.1016/j.jhep.2006.05.013
2. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002. Ca-A Cancer Journal for Clinicians 2005 55 2 74 108 2-s2.0-14944385553
3. El-Serag H. B., Rudolph K. L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007 132 7 2557 2576 2-s2.0-34250020201 10.1053/j.gastro.2007.04.061
4. Guerrieri F., Belloni L., Pediconi N., Levrero M., Molecular mechanisms of HBV-associated hepatocarcinogenesis. Seminars in Liver Disease 2013 33 2 147 156
5. Li Y., Chenc L., Hon Man Chan T., Hepatocellular carcinoma: transcriptome diversity regulated by RNA editing. The International Journal of Biochemistry & Cell Biology 2013 45 8 1843 1848
6. Hagymási K., Tulassay Z., Epidimiology, risk factors and molecular pathogenesis of primary liver cancer. Orvosi Hetilap 2008 149 12 541 548 2-s2.0-42049095149 10.1556/OH.2008.28313
7. Wong C. M., Kai A. K., Tsang F. H., Ng I. O., Regulation of hepatocarcinogenesis by microRNAs. Frontiers in Bioscience 2013 5 49 60
8. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5
9. Zhang B., Pan X., Cobb G. P., Anderson T. A., microRNAs as oncogenes and tumor suppressors. Developmental Biology 2007 302 1 1 12 2-s2.0-33846188098 10.1016/j.ydbio.2006.08.028
10. Takebe N., Harris P. J., Warren R. Q., Ivy S. P., Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nature Reviews Clinical Oncology 2011 8 2 97 106 2-s2.0-79551600015 10.1038/nrclinonc.2010.196
11. Wang X., Hu G., Zhou J., Repression of versican expression by microRNA-143. Journal of Biological Chemistry 2010 285 30 23241 23250 2-s2.0-77954890718 10.1074/jbc.M109.084673
12. Kong Y. W., Ferland-McCollough D., Jackson T. J., microRNAs in cancer management. The Lancet Oncology 2012 13 6 e249 e258
13. Slaby O., Bienertova-Vasku J., Svoboda M., Vyzula R., Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. Journal of Cellular and Molecular Medicine 2012 16 1 8 21 2-s2.0-84855169735 10.1111/j.1582-4934.2011.01359.x
14. Bartels C. L., Tsongalis G. J., Mini-reviews micrornas:novel biomarkers for human cancer. Clinical Chemistry 2009 55 4 623 631 2-s2.0-64149132942 10.1373/clinchem.2008.112805
15. Chen L., Yan H.-X., Yang W., Hu L., Yu L.-X., Liu Q., Li L., Huang D.-D., Ding J., Shen F., Zhou W.-P., Wu M.-C., Wang H.-Y., The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. Journal of Hepatology 2009 50 2 358 369 2-s2.0-58149277310 10.1016/j.jhep.2008.09.015
16. Jeon H. S., Lee Y. H., Lee S. Y., A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene 2014 534 1 66 71
17. Chae Y. S., Kim J. G., Lee S. J., A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. Anticancer Research 2013 33 8 3233 3239
18. Hasani S. S., Hashemi M., Eskandari-Nasab E., A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report. Tumor Biology 2014 35 1 219 225
19. Wei J., Zheng L., Liu S., MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Human Immunology 2013 74 9 1199 1205
20. Wei W. J., Wang Y. L., Li D. S., Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis. PLoS ONE 2013 8 2 e56638
21. Handoll H. H., Systematic reviews on rehabilitation interventions. Archives of Physical Medicine and Rehabilitation 2006 87 6, article 875 2-s2.0-33646799809 10.1016/j.apmr.2006.04.006
22. Mantel N., Haenszel W., Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959 22 4 719 748
23. DerSimonian R., Laird N., Meta-analysis in clinical trials. Controlled Clinical Trials 1986 7 3 177 188 2-s2.0-0022992740
24. Egger M., Smith G. D., Schneider M., Minder C., Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997 315 7109 629 634 2-s2.0-0030922816
25. Akkiz H., Bayram S., Bekar A., Akgöllü E., Ülger Y., A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. Journal of Viral Hepatitis 2011 18 7 e399 e407 2-s2.0-79955106168 10.1111/j.1365-2893.2010.01414.x
26. Akkiz H., Bayram S., Bekar A., Akgöllü E., Üsküdar O., Sandikçi M., No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene 2011 486 1-2 104 109 2-s2.0-84860390411 10.1016/j.gene.2011.07.006
27. Han Y., Pu R., Han X., Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS ONE 2013 8 3 e58564
28. Hao Y. X., Wang J. P., Zhao L. F., Associations between three common MicroRNA polymorphisms and hepatocellular carcinoma risk in Chinese. Asian Pacific Journal of Cancer Prevention 2013 14 11 6601 6604
29. Huang Q., Huang T.-R., Li J.-L., Correlation between microRNA-146a polymorphism and primary liver carcinoma in the Guangxi Zhuang population. Chinese Journal of Cancer Prevention and Treatment 2013 02 100 104
30. Kim W. H., Min K. T., Jeon Y. J., Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 2012 504 1 92 97
31. Li X.-D., Li Z.-G., Song X.-X., Liu C.-F., A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 2010 42 7 669 673 2-s2.0-78649305959 10.3109/00313025.2010.522175
32. Li Y., MicroRNA Related SNPs and Genetic Susceptibility to Hepatocellular Carcinoma 2012 Zhengzhou University
33. Qi P., Dou T.-H., Geng L., Zhou F.-G., Gu X., Wang H., Gao C.-F., Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Human Immunology 2010 71 6 621 626 2-s2.0-77952885135 10.1016/j.humimm.2010.02. 017
34. Wang W., Association of MiR-146a Single Nucleotide Polymorphism with Susceptibility to Hepatocellular Carcinoma and the Microarray Analysis of Tumor Related MicroRNAs 2011 Fudan
35. Xiang Y., Fan S., Cao J., Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Molecular Biology Reports 2012 39 6 7019 7023
36. Xu T., Zhu Y., Wei Q.-K., Yuan Y., Zhou F., Ge Y.-Y., Yang J.-R., Su H., Zhuang S.-M., A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008 29 11 2126 2131 2-s2.0-56049092548 10.1093/carcin/bgn195
37. Xu Y., Association Study of Polymorphisms in MiRNAs Genes with the Susceptibility of Hepatocellular Carcinoma 2010 Nanjing Medical University
38. Yu L., Association of the MicroRNA-499Variants with Susceptibilityto Hepatocellular Carcinomain the Southwest-China Population 2012 Chongqing Medical University
39. Zhang X.-W., Pan S.-D., Feng Y.-L., Liu J.-B., Dong J., Zhang Y.-X., Chen J.-G., Hu Z.-B., Shen H.-B., Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 2011 45 3 239 243 2-s2.0-84555191671
40. Zhang J., Wang R., Ma Y. Y., Association between single nucleotide polymorphisms in miRNA196a-2 and miRNA146a and susceptibility to hepatocellular carcinoma in a chinese population. Asian Pacific Journal of Cancer Prevention 2013 14 11 6427 6431
41. Zhou J., Lv R., Song X., Li D., Hu X., Ying B., Wei Y., Wang L., Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA and Cell Biology 2012 31 4 524 530 2-s2.0-84859741447 10.1089/dna.2011.1340
42. Giordano S., Columbano A., MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 2013 57 2 840 847
43. Ngamruengphong S., Patel T., Molecular evolution of genetic susceptibility to hepatocellular carcinoma. Digestive Diseases and Sciences. In press
44. Zeng Y., Cullen B. R., Sequence requirements for micro RNA processing and function in human cells. RNA 2003 9 1 112 123 2-s2.0-0037273432 10.1261/rna.2780503
45. Zhan J.-F., Chen L.-H., Chen Z.-X., Yuan Y.-W., Xie G.-Z., Sun A.-M., Liu Y., A functional variant in MicroRNA-196a2 is associated with susceptibility of colorectal cancer in a chinese population. Archives of Medical Research 2011 42 2 144 148 2-s2.0-79955714856 10.1016/j.arcmed.2011.04.001
46. Pavlakis E., Papaconstantinou I., Gazouli M., MicroRNA gene polymorphisms in pancreatic cancer. Pancreatology 2013 13 3 273 278
47. Luthra R., Singh R. R., Luthra M. G., Li Y. X., Hannah C., Romans A. M., Barkoh B. A., Chen S. S., Ensor J., Maru D. M., Broaddus R. R., Rashid A., Albarracin C. T., MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008 27 52 6667 6678 2-s2.0-56149126489 10.1038/onc.2008.256
48. Wang Z., Cao Y., Jiang C., Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS ONE 2012 7 6 e40039
49. Hu M., Zhao L., Hu S., The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population. PLoS ONE 2013 8 2 e57012
50. Xu Y., Li L., Xiang X., Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Gene 2013 527 2 584 593
51. Ayub A., Ashfaq U. A., Haque A., HBV induced HCC: major risk factors from genetic to molecular level. BioMed Research International 2013 2013 14 810461 10.1155/2013/810461